Xenpozyme
Xenpozyme ingredients
| Active ingredient | Strength |
|---|---|
| Olipudase Alfa | 20 mg/5.1mL, 4 mg/1.1mL |
What Xenpozyme is used for
The FDA lists the approved uses on the official label (below). In the EU, olipudase alfa is approved as Xenpozyme for:
Xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-Central Nervous System (CNS) manifestations of Acid Sphingomyelinase Deficiency (ASMD) in paediatric and adult patients with type A/B or type B.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Xenpozyme
- Generic name
- Olipudase alfa-rpcp
- Made by
- Genzyme Corporation
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous
- FDA approval
- Biologic licence (BLA) BLA761261
- On the US market since
- 2022
Official information
- Xenpozyme prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Olipudase alfa-rpcp)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Xenpozyme?
Xenpozyme (Olipudase alfa-rpcp) is a specialist medicine made by Genzyme Corporation, approved by the US FDA.
What are the ingredients of Xenpozyme?
Xenpozyme contains Olipudase Alfa (20 mg/5.1mL, 4 mg/1.1mL).
Is Xenpozyme approved in Europe?
The same active substance is approved in the EU as Xenpozyme.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA